Silk Road Medical (SILK) Stock Forecast, Price Target & Predictions

OverviewRevenue Ownership Financials Chart Transcripts

SILK Stock Forecast

Silk Road Medical stock forecast is as follows: an average price target of $29.75 (represents a 8.22% upside from SILK’s last price of $27.49) and a rating consensus of 'Buy', based on 7 wall street analysts offering a 1-year stock forecast.

SILK Price Target

The average price target for Silk Road Medical (SILK) is $29.75 based on 1-year price targets from 7 Wall Street analysts in the past 3 months, with a price target range of $32.00 to $27.50. This represents a potential 8.22% upside from SILK's last price of $27.49.

SILK Analyst Ratings

Buy

According to 7 Wall Street analysts, Silk Road Medical's rating consensus is 'Buy'. The analyst rating breakdown for SILK stock is 0 'Strong Buy' (0.00%), 4 'Buy' (57.14%), 3 'Hold' (42.86%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Silk Road Medical Price Target by Analyst

Date	Analyst	Company	Price Target	Price when Published	Price Target/Price when Published	Price Target/Last Closing Price
Jun 18, 2024	Frank Takkinen	Lake Street	$27.50	$26.80	2.59%	0.04%
Jun 14, 2024	David Toung	Argus Research	$32.00	$21.19	51.01%	16.41%
May 01, 2024	Adam Maeder	Piper Sandler	$20.00	$18.26	9.53%	-27.25%
Apr 03, 2024	Frank Takkinen	Loop Capital Markets	$28.00	$17.43	60.64%	1.86%
Mar 07, 2024	Steve Silver	Argus Research	$24.00	$15.98	50.19%	-12.70%
Sep 06, 2023	Suraj Kalia	Oppenheimer	$30.00	$19.14	56.74%	9.13%
Jul 18, 2022		Stifel Nicolaus	$46.00	$39.36	16.86%	67.33%
Apr 06, 2022	Adam Maeder	Piper Sandler	$43.00	$42.97	0.07%	56.42%

The latest Silk Road Medical stock forecast, released on Jun 18, 2024 by Frank Takkinen from Lake Street, set a price target of $27.50, which represents a 2.59% increase from the stock price at the time of the forecast ($26.80), and a 0.04% increase from SILK last price ($27.49).

Silk Road Medical Price Target by Period

	1M	3M	12M
# Anlaysts	-	-	5
Avg Price Target	-	-	$26.30
Last Closing Price	$27.49	$27.49	$27.49
Upside/Downside	-100.00%	-100.00%	-4.33%

In the current month, the average price target of Silk Road Medical stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Silk Road Medical's last price of $27.49. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades

Date	Company	Previous Rating	New Rating	Rating Change
Jun 18, 2024	Lake Street	Buy	Hold	Downgrade
May 01, 2024	Piper Sandler	Neutral	Neutral	Hold
Apr 29, 2024	Lake Street	Buy	Buy	Hold
Apr 03, 2024	Lake Street	Buy	Buy	Hold
Jan 19, 2024	Raymond James		Buy	Upgrade
Sep 06, 2023	Oppenheimer		Outperform	Initialise
Jul 12, 2023	J.P. Morgan		Neutral	Downgrade
May 22, 2023	Argus Research	Buy	Buy	Hold
May 15, 2023	Wolfe Research		Underperform	Downgrade
Apr 03, 2023	Citigroup	Neutral	Buy	Upgrade
Apr 06, 2022	Piper Sandler	Neutral	Neutral	Hold
Feb 25, 2022	Citigroup	Neutral	Neutral	Hold

Silk Road Medical's last stock rating was published by Lake Street on Jun 18, 2024. The company Downgrade its SILK rating from "Buy" to "Hold".

Silk Road Medical Financial Forecast

Silk Road Medical Revenue Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19	Mar 19
Revenue	-	-	-	-	-	-	-	-	-	$44.44M	$45.30M	$40.13M	$40.07M	$37.37M	$33.17M	$28.02M	$28.27M	$24.70M	$26.46M	$22.05M	$21.13M	$20.07M	$15.09M	$18.93M	$18.63M	$17.03M	$14.93M	$12.77M
Avg Forecast	$58.94M	$55.20M	$55.16M	$52.45M	$50.91M	$48.75M	$49.74M	$44.67M	$41.93M	$44.53M	$43.24M	$40.69M	$37.35M	$33.40M	$31.04M	$27.10M	$25.91M	$24.32M	$25.34M	$21.29M	$21.35M	$19.59M	$9.47M	$17.33M	$17.97M	$15.90M	$13.64M	$12.19M
High Forecast	$58.94M	$55.20M	$55.16M	$52.45M	$50.91M	$49.62M	$49.74M	$44.67M	$42.34M	$44.69M	$43.24M	$40.69M	$37.35M	$33.40M	$31.04M	$27.10M	$25.91M	$24.32M	$25.34M	$21.29M	$21.35M	$19.59M	$9.47M	$17.33M	$17.97M	$15.90M	$13.64M	$12.19M
Low Forecast	$58.94M	$55.20M	$55.16M	$52.45M	$50.91M	$47.60M	$49.74M	$44.67M	$41.70M	$44.36M	$43.24M	$40.69M	$37.35M	$33.40M	$31.04M	$27.10M	$25.91M	$24.32M	$25.34M	$21.29M	$21.35M	$19.59M	$9.47M	$17.33M	$17.97M	$15.90M	$13.64M	$12.19M
# Analysts	1	1	1	1	2	4	2	4	7	5	6	3	2	2	2	2	3	4	5	6	6	3	3	3	2	2	3	4
Surprise %	-	-	-	-	-	-	-	-	-	1.00%	1.05%	0.99%	1.07%	1.12%	1.07%	1.03%	1.09%	1.02%	1.04%	1.04%	0.99%	1.02%	1.59%	1.09%	1.04%	1.07%	1.09%	1.05%

Silk Road Medical's average Quarter revenue forecast for Dec 23 based on 7 analysts is $41.93M, with a low forecast of $41.70M, and a high forecast of $42.34M. SILK's average Quarter revenue forecast represents a -5.63% decrease compared to the company's last Quarter revenue of $44.44M (Sep 23).

Silk Road Medical EBITDA Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19	Mar 19
# Analysts	1	1	1	1	2	4	2	4	7	5	6	3	2	2	2	2	3	4	5	6	6	3	3	3	2	2	3	4
EBITDA	-	-	-	-	-	-	-	-	-	$-13.67M	$-11.77M	$-13.79M	$-10.88M	$-8.61M	$-14.12M	$-16.06M	$-13.49M	$-12.76M	$-9.45M	$-9.67M	$-15.59M	$-8.75M	$-8.82M	$-8.41M	$-6.75M	$-6.51M	$-10.44M	$-22.47M
Avg Forecast	$-24.87M	$-23.29M	$-23.27M	$-22.13M	$-21.48M	$-20.57M	$-20.98M	$-15.59M	$-17.69M	$-18.79M	$-18.24M	$-14.17M	$-12.37M	$-14.09M	$-13.09M	$-12.88M	$-10.93M	$-10.26M	$-10.69M	$-11.66M	$-9.01M	$-8.27M	$-3.99M	$-8.14M	$-7.58M	$-6.71M	$-5.75M	$-1.23B
High Forecast	$-24.87M	$-23.29M	$-23.27M	$-22.13M	$-21.48M	$-20.08M	$-20.98M	$-12.47M	$-17.59M	$-18.72M	$-18.24M	$-11.34M	$-9.89M	$-14.09M	$-13.09M	$-10.31M	$-10.93M	$-10.26M	$-10.69M	$-9.33M	$-9.01M	$-8.27M	$-3.99M	$-6.51M	$-7.58M	$-6.71M	$-5.75M	$-984.86M
Low Forecast	$-24.87M	$-23.29M	$-23.27M	$-22.13M	$-21.48M	$-20.93M	$-20.98M	$-18.70M	$-17.86M	$-18.86M	$-18.24M	$-17.00M	$-14.84M	$-14.09M	$-13.09M	$-15.46M	$-10.93M	$-10.26M	$-10.69M	$-13.99M	$-9.01M	$-8.27M	$-3.99M	$-9.77M	$-7.58M	$-6.71M	$-5.75M	$-1.48B
Surprise %	-	-	-	-	-	-	-	-	-	0.73%	0.65%	0.97%	0.88%	0.61%	1.08%	1.25%	1.23%	1.24%	0.88%	0.83%	1.73%	1.06%	2.21%	1.03%	0.89%	0.97%	1.81%	0.02%

undefined analysts predict SILK's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Silk Road Medical's previous annual EBITDA (undefined) of $NaN.

Silk Road Medical Net Income Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19	Mar 19
# Analysts	1	1	1	1	2	4	2	4	7	5	6	3	2	2	2	2	3	4	5	6	6	3	3	3	2	2	3	4
Net Income	-	-	-	-	-	-	-	-	-	$-12.79M	$-13.48M	$-16.01M	$-12.60M	$-11.41M	$-14.64M	$-17.40M	$-15.33M	$-13.88M	$-10.54M	$-10.69M	$-16.76M	$-10.31M	$-10.35M	$-9.94M	$-8.29M	$-8.01M	$-11.96M	$-24.16M
Avg Forecast	$-11.59M	$-12.48M	$-12.92M	$-15.21M	$-13.98M	$-15.11M	$-14.81M	$-16.74M	$-16.67M	$-13.97M	$-15.42M	$-15.21M	$-13.47M	$-17.90M	$-17.78M	$-13.83M	$-14.15M	$-12.89M	$-14.47M	$-12.89M	$-11.07M	$-11.30M	$-14.60M	$-9.62M	$-10.57M	$-10.70M	$-10.77M	$-1.32B
High Forecast	$-11.59M	$-12.48M	$-12.92M	$-15.21M	$-13.98M	$-13.43M	$-14.81M	$-13.39M	$-12.92M	$-13.97M	$-15.42M	$-12.17M	$-10.77M	$-17.90M	$-17.78M	$-11.07M	$-14.15M	$-12.89M	$-14.47M	$-10.31M	$-11.07M	$-11.30M	$-14.60M	$-7.70M	$-10.57M	$-10.70M	$-10.77M	$-1.06B
Low Forecast	$-11.59M	$-12.48M	$-12.92M	$-15.21M	$-13.98M	$-16.79M	$-14.81M	$-20.08M	$-23.33M	$-13.97M	$-15.42M	$-18.26M	$-16.16M	$-17.90M	$-17.78M	$-16.60M	$-14.15M	$-12.89M	$-14.47M	$-15.47M	$-11.07M	$-11.30M	$-14.60M	$-11.54M	$-10.57M	$-10.70M	$-10.77M	$-1.59B
Surprise %	-	-	-	-	-	-	-	-	-	0.92%	0.87%	1.05%	0.94%	0.64%	0.82%	1.26%	1.08%	1.08%	0.73%	0.83%	1.51%	0.91%	0.71%	1.03%	0.78%	0.75%	1.11%	0.02%

Silk Road Medical's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. SILK's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).

Silk Road Medical SG&A Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19	Mar 19
# Analysts	1	1	1	1	2	4	2	4	7	5	6	3	2	2	2	2	3	4	5	6	6	3	3	3	2	2	3	4
SG&A	-	-	-	-	-	-	-	-	-	$36.01M	$35.83M	$34.08M	$32.52M	$28.82M	$27.70M	$27.27M	$27.59M	$25.05M	$22.55M	$21.19M	$20.87M	$19.20M	$15.76M	$19.69M	$18.16M	$17.06M	$14.13M	$13.87M
Avg Forecast	$54.34M	$50.88M	$50.85M	$48.35M	$46.93M	$44.94M	$45.86M	$27.37M	$38.66M	$41.05M	$39.86M	$24.88M	$25.30M	$30.79M	$28.61M	$22.62M	$23.88M	$22.42M	$23.36M	$19.63M	$19.68M	$18.06M	$8.73M	$15.97M	$16.57M	$14.66M	$12.57M	$11.24M
High Forecast	$54.34M	$50.88M	$50.85M	$48.35M	$46.93M	$45.75M	$45.86M	$32.84M	$39.03M	$41.20M	$39.86M	$29.86M	$30.35M	$30.79M	$28.61M	$27.14M	$23.88M	$22.42M	$23.36M	$19.63M	$19.68M	$18.06M	$8.73M	$15.97M	$16.57M	$14.66M	$12.57M	$11.24M
Low Forecast	$54.34M	$50.88M	$50.85M	$48.35M	$46.93M	$43.89M	$45.86M	$21.89M	$38.45M	$40.90M	$39.86M	$19.90M	$20.24M	$30.79M	$28.61M	$18.09M	$23.88M	$22.42M	$23.36M	$19.63M	$19.68M	$18.06M	$8.73M	$15.97M	$16.57M	$14.66M	$12.57M	$11.24M
Surprise %	-	-	-	-	-	-	-	-	-	0.88%	0.90%	1.37%	1.29%	0.94%	0.97%	1.21%	1.16%	1.12%	0.97%	1.08%	1.06%	1.06%	1.81%	1.23%	1.10%	1.16%	1.12%	1.23%

Silk Road Medical's average Quarter SG&A projection for Dec 23 is $38.66M, based on 7 Wall Street analysts, with a range of $38.45M to $39.03M. The forecast indicates a 7.35% rise compared to SILK last annual SG&A of $36.01M (Sep 23).

Silk Road Medical EPS Forecast

	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19	Mar 19
# Analysts	1	1	1	1	2	4	2	4	7	5	6	3	2	2	2	2	3	4	5	6	6	3	3	3	2	2	3	4
EPS	-	-	-	-	-	-	-	-	-	$-0.33	$-0.35	$-0.42	$-0.33	$-0.32	$-0.42	$-0.50	$-0.44	$-0.40	$-0.31	$-0.31	$-0.49	$-0.31	$-0.32	$-0.32	$-0.27	$-0.26	$-0.42	$-0.84
Avg Forecast	$-0.29	$-0.32	$-0.33	$-0.38	$-0.35	$-0.38	$-0.37	$-0.40	$-0.42	$-0.35	$-0.39	$-0.40	$-0.38	$-0.45	$-0.45	$-0.37	$-0.36	$-0.33	$-0.37	$-0.39	$-0.28	$-0.29	$-0.37	$-0.31	$-0.27	$-0.27	$-0.27	$-0.32
High Forecast	$-0.29	$-0.32	$-0.33	$-0.38	$-0.35	$-0.34	$-0.37	$-0.40	$-0.33	$-0.35	$-0.39	$-0.40	$-0.38	$-0.45	$-0.45	$-0.37	$-0.36	$-0.33	$-0.37	$-0.39	$-0.28	$-0.29	$-0.37	$-0.31	$-0.27	$-0.27	$-0.27	$-0.32
Low Forecast	$-0.29	$-0.32	$-0.33	$-0.38	$-0.35	$-0.42	$-0.37	$-0.40	$-0.59	$-0.35	$-0.39	$-0.40	$-0.38	$-0.45	$-0.45	$-0.37	$-0.36	$-0.33	$-0.37	$-0.39	$-0.28	$-0.29	$-0.37	$-0.31	$-0.27	$-0.27	$-0.27	$-0.32
Surprise %	-	-	-	-	-	-	-	-	-	0.94%	0.90%	1.05%	0.88%	0.71%	0.94%	1.35%	1.23%	1.23%	0.85%	0.79%	1.75%	1.09%	0.87%	1.04%	1.01%	0.96%	1.54%	2.66%

According to undefined Wall Street analysts, Silk Road Medical's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to SILK previous annual EPS of $NaN (undefined).

Silk Road Medical Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
LUNG	Pulmonx	$6.13	$13.00	112.07%	Buy
SGHT	Sight Sciences	$3.62	$7.50	107.18%	Hold
RXST	RxSight	$38.04	$70.14	84.38%	Buy
TMDX	TransMedics Group	$65.71	$116.33	77.04%	Buy
KIDS	OrthoPediatrics	$22.46	$39.50	75.87%	Buy
LIVN	LivaNova	$49.94	$68.25	36.66%	Buy
OFIX	Orthofix Medical	$17.93	$24.00	33.85%
SIBN	SI-BONE	$13.84	$18.50	33.67%	Buy
NPCE	NeuroPace	$11.52	$15.00	30.21%	Buy
NARI	Inari Medical	$56.16	$64.00	13.96%	Buy
FNA	Paragon 28	$10.36	$11.50	11.00%	Buy

SILK Forecast FAQ

Is Silk Road Medical a good buy?

Yes, according to 7 Wall Street analysts, Silk Road Medical (SILK) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 4 'Buy' recommendations, accounting for 57.14% of SILK's total ratings.

What is SILK's price target?

Silk Road Medical (SILK) average price target is $29.75 with a range of $27.5 to $32, implying a 8.22% from its last price of $27.49. The data is based on 7 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Silk Road Medical stock go up soon?

According to Wall Street analysts' prediction for SILK stock, the company can go up by 8.22% (from the last price of $27.49 to the average price target of $29.75), up by 16.41% based on the highest stock price target, and up by 0.04% based on the lowest stock price target.

Can Silk Road Medical stock reach $40?

SILK's average twelve months analyst stock price target of $29.75 does not support the claim that Silk Road Medical can reach $40 in the near future.

What are Silk Road Medical's analysts' financial forecasts?

Silk Road Medical's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $194.07M (high $194.95M, low $192.93M), average EBITDA is $-78.616M (high $-75.016M, low $-82.102M), average net income is $-60.637M (high $-55.611M, low $-65.664M), average SG&A $165.1M (high $171.38M, low $158.57M), and average EPS is $-1.511 (high $-1.468, low $-1.553). SILK's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $221.74M (high $221.74M, low $221.74M), average EBITDA is $-93.55M (high $-93.55M, low $-93.55M), average net income is $-52.201M (high $-52.201M, low $-52.201M), average SG&A $204.42M (high $204.42M, low $204.42M), and average EPS is $-1.317 (high $-1.317, low $-1.317).

Did the SILK's actual financial results beat the analysts' financial forecasts?

Based on Silk Road Medical's last annual report (Dec 2022), the company's revenue was $138.64M, beating the average analysts forecast of $128.88M by 7.57%. Apple's EBITDA was $-49.667M, missing the average prediction of $-52.433M by -5.28%. The company's net income was $-58.016M, missing the average estimation of $-62.979M by -7.88%. Apple's SG&A was $116.32M, beating the average forecast of $107.32M by 8.38%. Lastly, the company's EPS was $-1.62, missing the average prediction of $-1.649 by -1.73%. In terms of the last quarterly report (Sep 2023), Silk Road Medical's revenue was $44.44M, missing the average analysts' forecast of $44.53M by -0.21%. The company's EBITDA was $-13.671M, missing the average prediction of $-18.786M by -27.23%. Silk Road Medical's net income was $-12.788M, missing the average estimation of $-13.968M by -8.45%. The company's SG&A was $36.01M, missing the average forecast of $41.05M by -12.28%. Lastly, the company's EPS was $-0.33, missing the average prediction of $-0.353 by -6.39%